Jefferies Group's COGT Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 188,159 shares of Cogent Biosciences, Inc. (COGT) worth $7.28 M, representing 0.05% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Jefferies Group has maintained this position in COGT for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 132,585 shares. Largest reduction occurred in Q1 2026, reducing 19,538 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Cogent Biosciences (COGT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Cogent Biosciences (COGT) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +132,585 | Add 238.57% | 188,159 | $38.70 |
| Q1 2026 | -19,538 | Reduce 26.01% | 55,574 | $38.49 |
| Q4 2025 | +75,112 | New Buy | 75,112 | $35.52 |
Jefferies Group's Cogent Biosciences Investment FAQs
Jefferies Group first purchased Cogent Biosciences, Inc. (COGT) in Q4 2025, acquiring 75,112 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Cogent Biosciences, Inc. (COGT) for 3 quarters since Q4 2025.
Jefferies Group's largest addition to Cogent Biosciences, Inc. (COGT) was in Q2 2026, adding 188,159 shares worth $7.28 M.
According to the latest 13F filing for Q2 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 188,159 shares of Cogent Biosciences, Inc. (COGT), valued at approximately $7.28 M.
As of the Q2 2026 filing, Cogent Biosciences, Inc. (COGT) represents approximately 0.05% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Cogent Biosciences, Inc. (COGT) was 188,159 shares, as reported at the end of Q2 2026.